Philippe Eggimann

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


213 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | ...
2024
Serial monitoring of pancreatic stone protein for the detection of sepsis in intensive care unit patients with complicated abdominal surgery: A prospective, longitudinal cohort study.
Filippidis P., Hovius L., Tissot F., Orasch C., Flückiger U., Siegemund M., Pagani J.L., Eggimann P., Marchetti O., Lamoth F. et al., 2024/03/11. Journal of critical care, 82 p. 154772. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BB2800A65195]
2023
Discriminative performance of pancreatic stone protein in predicting ICU mortality and infection severity in adult patients with infection: a systematic review and individual patient level meta-analysis.
Zuercher P., Moser A., Garcia de Guadiana-Romualdo L., Llewelyn M.J., Graf R., Reding T., Eggimann P., Que Y.A., Prazak J., 2023/12. Infection, 51 (6) pp. 1797-1807. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B004A84BAE70]
Best practice in the use of peripheral venous catheters: A scoping review and expert consensus.
Zingg W., Barton A., Bitmead J., Eggimann P., Pujol M., Simon A., Tatzel J., 2023/06. Infection prevention in practice, 5 (2) p. 100271. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BC1F8531E432]
The effect of duration of antimicrobial treatment for bacteremia in critically ill patients on in-hospital mortality - Retrospective double center analysis.
Zuercher P., Moser A., Frey M.C., Pagani J.L., Buetti N., Eggimann P., Daneman N., Fowler R., Que Y.A., Prazak J., 2023/04. Journal of critical care, 74 p. 154257. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8749F3ABAD84]
2022
 
Corrigendum to "Validation and clinical application of a multiplex high performance liquid chromatography - Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections" [J. Chromatogr. B 1157 (2020) 122160].
Decosterd L.A., Mercier T., Ternon B., Cruchon S., Guignard N., Lahrichi S., Pesse B., Rochat B., Burger R., Lamoth F. et al., 2022/11/15..
[DOI][WoS][Pmid][serval:BIB_D81DA54DDABE]
 
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Chastre J., François B., Bourgeois M., Komnos A., Ferrer R., Rahav G., De Schryver N., Lepape A., Koksal I., Luyt C.E. et al., 2022/11/15. Critical care, 26 (1) p. 355. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_851C736F5621]
 
Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE Study.
Ruzin A., Barraud O., Yu L., François B., Sánchez-Garcia M., Eggimann P., Dequin P.F., Laterre P.F., Huberlant V., Viña L. et al., 2022/07/20. Journal of clinical microbiology, 60 (7) pp. e0034722. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_994F166CF656]
2021
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.
Battistolo J., Glampedakis E., Damonti L., Poissy J., Grandbastien B., Kalbermatter L., Pagani J.L., Eggimann P., Bochud P.Y., Calandra T. et al., 2021/12. Mycoses, 64 (12) pp. 1512-1520. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_59B304F1CB77]
 
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
François B., Jafri H.S., Chastre J., Sánchez-García M., Eggimann P., Dequin P.F., Huberlant V., Viña Soria L., Boulain T., Bretonnière C. et al., 2021/09. The Lancet. Infectious diseases, 21 (9) pp. 1313-1323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_521881AEAFC2]
Accuracy of pancreatic stone protein for the diagnosis of infection in hospitalized adults: a systematic review and individual patient level meta-analysis.
Prazak J., Irincheeva I., Llewelyn M.J., Stolz D., García de Guadiana Romualdo L., Graf R., Reding T., Klein H.J., Eggimann P., Que Y.A., 2021/05/28. Critical care, 25 (1) p. 182. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F0483B20B261]
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study.
Pugin J., Daix T., Pagani J.L., Morri D., Giacomucci A., Dequin P.F., Guitton C., Que Y.A., Zani G., Brealey D. et al., 2021/04/20. Critical care, 25 (1) p. 151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E46CA007B5DF]
2020
 
Chlorhexidine-dress related contact dermatitis-the precautionary principle is no more relevant!
Eggimann P., Pagani J.L., Revelly J.P., Que Y.A., 2020/12/09. Critical care, 24 (1) p. 687. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4252A18BDB62]
Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
Decosterd L.A., Mercier T., Ternon B., Cruchon S., Guignard N., Lahrichi S., Pesse B., Rochat B., Burger R., Lamoth F. et al., 2020/11/10. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1157 p. 122160. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2ABB9B287690]
Avec la baisse prévisible des coûts à charge des assurances maladie en 2020 pour cause de covid, les primes 2021 doivent diminuer d’au moins 4 %.
Eggimann P., Matter M., Gusmini W., Marie J.M., Schwarz C., Hagen M.L., 2020/09/09. Revue medicale suisse, 16 (705) pp. 1664-1665. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9056CAF08AE4]
Coronella, pour une surveillance efficace du COVID-19.
Bovier P., Eggimann P., 2020/05/06. Revue medicale suisse, 16 (692) p. 962. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_56A588DE7B14]
Impacts organisationnels et défis cliniques de la pandémie COVID-19 pour un service hospitalier de médecine interne universitaire [Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department]
Garnier A., Vaucher J., Bianchi C., Kraege V., Méan M., Castioni J., Bart P.A., Champier V., Eggimann P., Gachoud D. et al., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 869-874. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C4B18AADE722]
Covid-19 - Mourir riche ou puiser dans le bas de laine
Eggimann P., 2020/04/22. Revue medicale suisse, 16 (691) p. 797. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F0C8BC9D5E07]
Il est urgent d’aider les cabinets médicaux.
Eggimann P., 2020/04/15. Revue medicale suisse, 16 (690) pp. 752-753. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9F3D6CD3345E]
Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis.
Lamoth F., Clancy C.J., Tissot F., Squires K., Eggimann P., Flückiger U., Siegemund M., Orasch C., Zimmerli S., Calandra T. et al., 2020/03. Open forum infectious diseases, 7 (3) pp. ofaa075. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_55AFFF4235BB]
2019
 
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.
Weiss E., Zahar J.R., Alder J., Asehnoune K., Bassetti M., Bonten MJM, Chastre J., De Waele J., Dimopoulos G., Eggimann P. et al., 2019/11/13. Clinical infectious diseases, 69 (11) pp. 1912-1918. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F0650CF235A2]
 
Gel des primes 2020 : on y est presque ! []
Eggimann P., Matter M., 2019/09/11. Revue medicale suisse, 15 (662) p. 1644. Peer-reviewed.
[Pmid][serval:BIB_3F949D5D1AC7]
 
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Tacconelli E., Mazzaferri F., de Smet A.M., Bragantini D., Eggimann P., Huttner B.D., Kuijper E.J., Lucet J.C., Mutters N.T., Sanguinetti M. et al., 2019/07. Clinical microbiology and infection, 25 (7) pp. 807-817. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_34A5FEB7B3D5]
 
Primes 2020 : halte à la désinformation, c’est une baisse qui s’impose !
Eggimann P., 2019/06/19. Revue medicale suisse, 15 (656) p. 1300. Peer-reviewed.
[Pmid][serval:BIB_0B63A7F88C1C]
Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years.
Eggimann P., Pagani J.L., Dupuis-Lozeron E., Ms B.E., Thévenin M.J., Joseph C., Revelly J.P., Que Y.A., 2019/06. Intensive care medicine, 45 (6) pp. 823-833. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF96B4DC9E06]
Measurement of pancreatic stone protein in the identification and management of sepsis.
Eggimann P., Que Y.A., Rebeaud F., 2019/02. Biomarkers in medicine, 13 (2) pp. 135-145. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6894DEBEEC4E]
2018
 
Reply to Sorooshian and Snow, "Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?"
Fournier A., Eggimann P., Pantet O., Pagani J.L., Dupuis-Lozeron E., Pannatier A., Sadeghipour F., Voirol P., Que Y.A., 2018/10. Antimicrobial agents and chemotherapy, 62 (10). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6277E33537AC]
 
Population Pharmacokinetic Study of Amoxicillin-Treated Burn Patients Hospitalized at a Swiss Tertiary-Care Center.
Fournier A., Goutelle S., Que Y.A., Eggimann P., Pantet O., Sadeghipour F., Voirol P., Csajka C., 2018/09. Antimicrobial agents and chemotherapy, 62 (9) pp. e00505-18. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_936107FB37E5]
 
Quel avenir pour la garde médicale dans le canton de Vaud ? []
Eggimann P., Repond P.A., 2018/04/04. Revue medicale suisse, 14 (601) p. 768. Peer-reviewed.
[Pmid][serval:BIB_5D47A2834DEB]
 
Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit.
Fournier A., Eggimann P., Pantet O., Pagani J.L., Dupuis-Lozeron E., Pannatier A., Sadeghipour F., Voirol P., Que Y.A., 2018/03. Antimicrobial agents and chemotherapy, 62 (3) pp. e01818-17 . Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F21C5CFE1632]
 
Coûts de la santé : ce que l’on vous cache… []
Eggimann P., 2018/02/21. Revue medicale suisse, 14 (595) pp. 437-440. Peer-reviewed.
[Pmid][serval:BIB_211D029EE3CE]
 
Arrêt cardiaque suite à l’administration accidentelle d’amphotéricine B sous forme désoxycholate
Cuda Loredana, Mury Caroline, Pagani Jean-Luc, Revelly Jean-Pierre, Livio Françoise, Aubert John-David, Schaller Marie-Denise, Voirol Pierre, Eggimann Philippe, Que Yok-Ai, 2018. Forum Medical Suisse, 18 (50) pp. 1067-1071. Peer-reviewed.
[serval:BIB_2D46003F1D03]
2017
 
Hand Hygiene Improvement and Sustainability: Assessing a Breakthrough Collaborative in Western Switzerland.
Staines A., Amherdt I., Lécureux E., Petignat C., Eggimann P., Schwab M., Pittet D., 2017/12. Infection control and hospital epidemiology, 38 (12) pp. 1420-1427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C1CD622D246D]
 
Coûts de la santé : arrêtons de nous lamenter ! []
Eggimann P., 2017/09/06. Revue medicale suisse, 13 (573) pp. 1542-1543. Peer-reviewed.
[Pmid][serval:BIB_7E039B97C020]
Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome.
Azoulay E., Knoebl P., Garnacho-Montero J., Rusinova K., Galstian G., Eggimann P., Abroug F., Benoit D., von Bergwelt-Baildon M., Wendon J. et al., 2017/08. Chest, 152 (2) pp. 424-434. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9D0B895EE7A7]
 
Staphylococcus aureus carriage at admission predicts early-onset pneumonia after burn trauma.
Fournier A., Voirol P., Krähenbühl M., Bonnemain C.L., Fournier C., Dupuis-Lozeron E., Pantet O., Pagani J.L., Revelly J.P., Sadeghipour F. et al., 2017/04. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 36 (3) pp. 523-528. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3570AFA2FB29]
 
Treatment of severe MRSA infections: current practice and further development.
Paiva J.A., Eggimann P., 2017/02. Intensive care medicine, 43 (2) pp. 233-236. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0C9AE0E62367]
Procalcitonin-Guided Antibiotics after Surgery for Peritonitis: A Randomized Controlled Study.
Slieker J.C., Aellen S., Eggimann P., Guarnero V., Schäfer M., Demartines N., 2017. Gastroenterology research and practice, 2017 p. 3457614. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5051308A22AD]
2016
New genotyping method discovers sustained nosocomial Pseudomonas aeruginosa outbreak in an intensive care burn unit.
Tissot F., Blanc D.S., Basset P., Zanetti G., Berger M.M., Que Y.A., Eggimann P., Senn L., 2016/09. The Journal of hospital infection, 94 (1) pp. 2-7.
[URN][DOI][Pmid][serval:BIB_8FB4BF675C6C]
 
The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.
François B., Chastre J., Eggiman P., Laterre P.F., Torres A., Sanchez M., Esser M.T., Bishop B., Bonten M., Goosens H. et al., 2016/08/15. Clinical infectious diseases, 63 Suppl 2 pp. S46-51. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DBECCA1A0EFD]
 
Therapeutic management of peritonitis: a comprehensive guide for intensivists.
Montravers P., Blot S., Dimopoulos G., Eckmann C., Eggimann P., Guirao X., Paiva J.A., Sganga G., De Waele J., 2016/08. Intensive care medicine, 42 (8) pp. 1234-1247. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_56571284D5F4]
Management of infections in critically ill returning travellers in the intensive care unit-II: clinical syndromes and special considerations in immunocompromised patients.
Rello J., Manuel O., Eggimann P., Richards G., Wejse C., Petersen J.E., Zacharowski K., Leblebicioglu H., ESGCIP and ESGITM, 2016/07. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 48 pp. 104-112. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A25B9CD64B78]
 
Antibiotic consumption to detect epidemics of Pseudomonas aeruginosa in a burn centre: A paradigm shift in the epidemiological surveillance of Pseudomonas aeruginosa nosocomial infections.
Fournier A., Voirol P., Krähenbühl M., Bonnemain C.L., Fournier C., Pantet O., Pagani J.L., Revelly J.P., Dupuis-Lozeron E., Sadeghipour F. et al., 2016/05. Burns : journal of the International Society for Burn Injuries, 42 (3) pp. 564-570. Peer-reviewed.
[DOI][Pmid][serval:BIB_3BB207157576]
Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis.
Stalder G., Que Y.A., Calzavarini S., Burnier L., Kosinski C., Ballabeni P., Roger T., Calandra T., Duchosal M.A., Liaudet L. et al., 2016. PloS one, 11 (10) pp. e0163542. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AE9847158368]
What is new in selective decontamination of the digestive tract?
Kesecioglu J., Eggimann P., 2016. Intensive Care Medicine, 42 (8) pp. 1270-1275. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2AE070C6DA43]
2015
 
A 3-step therapeutic strategy for severe alveolar proteinosis.
Noirez L., Koutsokera A., Pantet O., Duss F.R., Eggimann P., Tozzi P., Gonzalez M., Coronado M., Nicod L.P., Lovis A., 2015. Annals of Thoracic Surgery, 99 (4) pp. 1456-1458. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_032C94B12F21]
A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections.
Knitsch W., Vincent J.L., Utzolino S., François B., Dinya T., Dimopoulos G., Özgüneş İ., Valía J.C., Eggimann P., León C. et al., 2015. Clinical Infectious Diseases, 61 (11) pp. 1671-1678. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_89C88704E1A9]
 
Antibiotics' consumption to early detect epidemics of P. aeruginosa in a burn center: a paradigm shift in the epidemiological surveillance of nosocomial infections
Fournier A, Eggimann P, Pantet O, Krähenbühl M, Bonnemain C-L, Fournier C, Pagani J-L, Revelly J-P, Dupuis-Lozeron E, Sadeghipour F et al., 2015. pp. P232 dans 3rd International Conference on Prevention and Infection Control (ICPIC 2015), Antimicrobial Resistance and Infection Control. Peer-reviewed.
[DOI][serval:BIB_241408D41CDC]
 
Contextual effect of selective oral decontamination/selective decontamination of the digestive tract on candidemia: just another word of caution!
Charles P.E., Paiva J.A., Eggimann P., 2015. Intensive Care Medicine, 41 (12) pp. 2224-2226. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_574C04711231]
 
Effective Treatment of Invasive Aspergillus fumigatus Infection Using Combinations of Topical and Systemic Antifungals in a Severely Burned Patient.
Fournier A., Pantet O., Guerid S., Eggimann P., Pagani J.L., Revelly J.P., Hauser P.M., Marchetti O., Fontanella S., Letovanec I. et al., 2015. Journal of Burn Care and Research, 36 (2) pp. e85-e89. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7801E93C98E1]
 
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Fournier A., Eggimann P., Pagani J.L., Revelly J.P., Decosterd L.A., Marchetti O., Pannatier A., Voirol P., Que Y.A., 2015. Burns, 41 (5) pp. 956-968. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_250BAF754387]
 
Is It Time to Revisit Surgical Lung Biopsy in ARDS?
Charbonney E., Grondin-Beaudoin B., Eggimann P., 2015. Annals of Thoracic Surgery, 99 (5) p. 1865. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94889A1C1758]
Low C-reactive protein values at admission predict mortality in patients with severe community-acquired pneumonia caused by Streptococcus pneumoniae that require intensive care management.
Que Y.A., Virgini V., Lozeron E.D., Paratte G., Prod'hom G., Revelly J.P., Pagani J.L., Charbonney E., Eggimann P., 2015. Infection, 43 (2) pp. 193-199. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_237BD48AFB69]
 
Nouvelles stratégies dans la prise en charge: Infections complexes en médecine intensive
Eggimann P, Pagani JL, Seravalli L, Revelly JP, Que YA, 2015. Forum Medical Suisse, 15 (6) pp. 124-128. Peer-reviewed.
[serval:BIB_E0AA93EEDC15]
 
Preventing invasive candida infections. Where could we do better?
Eggimann P., Que Y.A., Revelly J.P., Pagani J.L., 2015. Journal of Hospital Infection, 89 (4) pp. 302-308. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_134619C45F58]
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.
Bassetti M., De Waele J.J., Eggimann P., Garnacho-Montero J., Kahlmeter G., Menichetti F., Nicolau D.P., Paiva J.A., Tumbarello M., Welte T. et al., 2015. Intensive Care Medicine, 41 (5) pp. 776-795. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A069D7526296]
 
The Role of Biomarkers for Starting Antifungals in the Intensive Care Unit
Pagani Jean-Luc, Revelly Jean-Pierre, Que Yok-Ai, Eggimann Philippe, 2015. Clinical Pulmonary Medicine, 22 (6) pp. 286-293. Peer-reviewed.
[DOI][serval:BIB_9142ACFAEC7D]
2014
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome.
De Waele J., Lipman J., Sakr Y., Marshall J.C., Vanhems P., Barrera Groba C., Leone M., Vincent J.L., EPIC II Investigators, 2014/07/29. BMC infectious diseases, 14 p. 420. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB9C66D54EB7]
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
Que Y.A., Lazar H., Wolff M., François B., Laterre P.F., Mercier E., Garbino J., Pagani J.L., Revelly J.P., Mus E. et al., 2014. European Journal of Clinical Microbiology and Infectious Diseases, 33 (10) pp. 1861-1867. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EDD8EE678A5D]
Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later.
Eggimann P., Pittet D., 2014. Intensive Care Medicine, 40 (10) pp. 1429-1448. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_907711BC5DE5]
 
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study.
Gustot T., Felleiter P., Pickkers P., Sakr Y., Rello J., Velissaris D., Pierrakos C., Taccone F.S., Sevcik P., Moreno C. et al., 2014. Liver International, 34 (10) pp. 1496-1503. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5787A3E38E98]
 
Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients*.
Wójtowicz A., Tissot F., Lamoth F., Orasch C., Eggimann P., Siegemund M., Zimmerli S., Flueckiger U.M., Bille J., Calandra T. et al., 2014. Critical Care Medicine, 42 (4) pp. e304-e308. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E94BE692A2A]
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes.
Lu Q., Eggimann P., Luyt C.E., Wolff M., Tamm M., François B., Mercier E., Garbino J., Laterre P.F., Koch H. et al., 2014. Critical Care, 18 (1) pp. R17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D38AF4AA68B5]
2013
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
Niven D.J., Laupland K.B., Tabah A., Vesin A., Rello J., Koulenti D., Dimopoulos G., de Waele J., Timsit J.F., EUROBACT Investigators, 2013/12/10. Critical care (London, England), 17 (6) pp. R289.
[URN][DOI][Pmid][serval:BIB_FBF5F4D4E761]
 
Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.
Montravers P., Dupont H., Eggimann P., 2013. Intensive Care Medicine, 39 (12) pp. 2226-2230.
[DOI][WoS][Pmid][serval:BIB_A95512482D31]
 
Serum procalcitonin as a marker of post-cardiac arrest syndrome and long-term neurological recovery, but not of early-onset infections, in comatose post-anoxic patients treated with therapeutic hypothermia.
Engel H., Ben Hamouda N., Portmann K., Delodder F., Suys T., Feihl F., Eggimann P., Rossetti A.O., Oddo M., 2013. Resuscitation, 84 (6) pp. 776-781. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_79F72B3AC260]
 
β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture-Negative Intraabdominal Candidiasis.
Tissot F., Lamoth F., Hauser P.M., Orasch C., Flückiger U., Siegemund M., Zimmerli S., Calandra T., Bille J., Eggimann P. et al., 2013. American Journal of Respiratory and Critical Care Medicine, 188 (9) pp. 1100-1109.
[DOI][WoS][Pmid][serval:BIB_5D0AA27187E7]
2012
 
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.
Tabah A., Koulenti D., Laupland K., Misset B., Valles J., Bruzzi de Carvalho F., Paiva J.A., Cakar N., Ma X., Eggimann P. et al., 2012. Intensive Care Medicine, 38 (12) pp. 1930-1945. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4E88CF8636E2]
 
Five-year evolution of drug prescribing in a university adult intensive care unit.
Carron C., Voirol P., Eggimann P., Pannatier A., Chioléro R., Wasserfallen J.B., 2012. Applied Health Economics and Health Policy, 10 (5) pp. 355-358. Peer-reviewed.
[DOI][Pmid][serval:BIB_D0F2D4E3DCA9]
 
Invasive Candida infections in the ICU
Eggimann P., Barberini L., Calandra T., Marchetti O., 2012. Mycoses, 55 (Suppl. 1) pp. 65-72. Peer-reviewed.
[DOI][WoS][serval:BIB_9B179B33AC10]
 
Le score SAPS prédit la mortalité posthospitalière à long terme des patients de réanimation.
Seravalli L., Eggimann P., Guessous I., Piquilloud L., Revelly J.P., 2012. pp. SP008 dans SRLF 2012, 41e Congrès de la Société de Réanimation de Langue Française, Réanimation.
[serval:BIB_F741C3DA8EA8]
Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management.
Que Y.A., Delodder F., Guessous I., Graf R., Bain M., Calandra T., Liaudet L., Eggimann P., 2012. Critical Care, 16 (4) pp. R114. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_55FF98C02326]
Renal perfusion evaluation with contrast-enhanced ultrasonography.
Schneider A.G., Hofmann L., Wuerzner G., Glatz N., Maillard M., Meuwly J.Y., Eggimann P., Burnier M., Vogt B., 2012. Nephrology, Dialysis, Transplantation, 27 (2) pp. 674-681. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0FBD29996D50]
 
The Sequential Organ Failure Assessment score and copeptin for predicting survival in ventilator-associated pneumonia.
Boeck L., Eggimann P., Smyrnios N., Pargger H., Thakkar N., Siegemund M., Morgenthaler N.G., Rakic J., Tamm M., Stolz D., 2012. Journal of Critical Care, 27 (5) pp. 523.e1-523.e9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8B5D4F9DA3F0]
2011
 
Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.
Kett D.H., Azoulay E., Echeverria P.M., Vincent J.L., Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators, 2011. Critical Care Medicine, 39 (4) pp. 665-670. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7CE83D9AE1CE]
Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports.
Kreienbuehl L., Charbonney E., Eggimann P., 2011. Annals of Intensive Care, 1 (1) p. 52. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CA8B854E6B69]
Diagnosis of invasive candidiasis in the ICU.
Eggimann P., Bille J., Marchetti O., 2011. Annals of Intensive Care, 1 p. 37. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9E2018780C4A]
 
Growth arrest-specific gene 6 (GAS6) as an intra-hospital mortality predictor for patients in septic shock
Stalder G., Kosinski C., Delodder F., Ternon B., Roger T., Calandra T., Duchosal M.A., Eggimann P., Angelillo-Scherrer A., 2011. p. 14 dans ISTH 2011, 23rd Congress of the International Society on Thrombosis and Haemostasis, 57th Annual SSC Meeting (Scientific and Standardization Committee), Journal of Thrombosis and Haemostasis. Peer-reviewed.
[WoS][serval:BIB_61DF0559A106]
 
Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest.
Cueni-Villoz N., Devigili A., Delodder F., Cianferoni S., Feihl F., Rossetti A.O., Eggimann P., Vincent J.L., Taccone F.S., Oddo M., 2011. Critical Care Medicine, 39 (10) pp. 2225-2231. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D170B0F08105]
Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?
Eggimann P., Marchetti O., 2011. Critical Care, 15 (6) p. 1017. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2A718AF5A7D8]
 
Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP.
Boeck L., Eggimann P., Smyrnios N., Pargger H., Thakkar N., Siegemund M., Marsch S., Rakic J., Tamm M., Stolz D., 2011. European Respiratory Journal, 37 (3) pp. 595-603. Peer-reviewed.
[DOI][Pmid][serval:BIB_B348B3168D7F]
Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10-year period (1998-2007).
Cuttelod M., Senn L., Terletskiy V., Nahimana I., Petignat C., Eggimann P., Bille J., Prod'hom G., Zanetti G., Blanc D.S., 2011/01. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 17 (1) pp. 57-62. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F3A85FA074BF]
 
Pancreatic stone protein: a marker of organ failure and outcome in ventilator-associated pneumonia.
Boeck L., Graf R., Eggimann P., Pargger H., Raptis D.A., Smyrnios N., Thakkar N., Siegemund M., Rakic J., Tamm M. et al., 2011. Chest, 140 (4) pp. 925-932. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45DF8753C8C7]
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.
Lu Q., Rouby J.J., Laterre P.F., Eggimann P., Dugard A., Giamarellos-Bourboulis E.J., Mercier E., Garbino J., Luyt C.E., Chastre J. et al., 2011. Journal of Antimicrobial Chemotherapy, 66 (5) pp. 1110-1116.
[URN][DOI][Pmid][serval:BIB_0345C72AA558]
 
Utilité des biomarqueurs du sepsis en réanimation [Usefulness of biomarkers of sepsis in the ICU].
Jolivet P., Christen G., Seematter G., Que Y.A., Eggimann P., 2011. Revue Médicale Suisse, 7 (321) pp. 2430-2434.
[Pmid][serval:BIB_7180A2EB53B9]
2010
 
Community-acquired Streptococcus pneumoniae requiring ICU admission
Virgini V, Prod'hom G., Greub G., Revelly J. P., Eggimann P., 2010/09., Swiss Society of Infectious Diseases pp. 45S dans Schweiz Med Forum. Peer-reviewed, EMH.
[serval:BIB_8C3E4EF9B022]
 
Cross-sectional audits of antimicrobial therapies (AMT) with feedback in viscera
Senn L, Cuttelod M., Eggimann P., Demartines N., Hugli O., Zanetti Z., 2010/09., Swiss Society of Infectious Diseases pp. 41S dans Schweiz Med Forum 2010. Peer-reviewed, EMH.
[serval:BIB_B1D4F2504EE8]
 
Impact of chlorhexidine-impregnated sponges on catheter-related infections rate
Joseph C., Thévenin M.J., Voirol P., Bellini B., Revelly J.P., Eggimann P., 2010/09., Société Suisse de Médecine Intensive pp. 2S dans Schweiz Med Forum. Peer-reviewed, EMH.
[serval:BIB_45FDD2862B0F]
 
Impact of Prospective Quarterly Audits on Pharmaceutical Costs in a 32-bed Mixed Adult ICU
Eggimann P, Voirol P., Chioléro R., Gattlen L., Mariotti G., Wasserfallen J. B., Jolliet P., 2010/09., Société Suisse de Médecine Intensive pp. 23S dans Schweiz Med Forum, EMH.
[serval:BIB_1721DA190094]
 
Impact of specific guidelines on antimicrobial use in a large mixed ICU
Senn L., Plüss-Suard C., Voirol P., Zanetti G., Eggimann P., 2010/09., Swiss Society of Infectious Diseases pp. 4S dans Schweiz Med Forum 2010;. Peer-reviewed, EMH.
[serval:BIB_B3F0C757E1E1]
 
Is donor management of older brain-dead patients more demanding?
Reichmuth P., Guessous I., Eggimann P., Pilon N., Revelly J.P., 2010/09., Société Suisse de Médecine Intensive pp. 6S dans Schweiz Med Forum. Peer-reviewed, EMH.
[serval:BIB_FCC961D44760]
 
One Year Prospective Evaluation of External Activities of a Medical ICU Team (MIT)
Uhlmann V., Eggimann P, Schaller M. D., Jolliet P., Pagani J. L., 2010/09., Société Suisse de Médecine Intensive pp. 24S dans Schweiz Med Forum. Peer-reviewed, EMH.
[serval:BIB_201675D71771]
 
Pancreatic stone protein (PSP): a biomarker of sepsis
Delodder F., Liaudet L., Que Y.A., Lajaunias F., Graf R., Bain M., Moreillon Philippe, Roger T., Calandra T., Eggimann P., 2010/09., Swiss Society of Infectious Diseases pp. 36S dans Schweiz Med Forum. Peer-reviewed, EMH.
[serval:BIB_4BFDA80A0EA1]
 
Peripartum-related cardiogenic shock? One train may hide another (Case-report)
Genton A., Kohut B., Schaller M.D., Revelly J. P., Hullin R., Tozzi P., Eggimann P., 2010/09., Société Suisse de Médecine Intensive pp. 15S dans Schweiz Med Forum. Peer-reviewed, EMH.
[serval:BIB_5586AED45186]
Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.
Schneider A.G., Perez M.H., Tozzi P., Voirol P., Schoettker P., Angelillo-Scherrer A., Cotting J., Von Segesser L., Eggimann P., 2010/09. Intensive care medicine, 36 (9) pp. 1620-1621. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_98A4B780B011]
 
Tight Glucose Control managed by ICU nurses induces extremely low Rates of Hypoglycemia
Joseph C., Delodder F., Maravic P., Szostek T., Schaller M.D., Berger M., Revelly J.P., Eggimann P., 2010/09., Société Suisse de Médecine Intensive pp. 6S dans Schweiz Med Forum 2010. Peer-reviewed, EMH.
[serval:BIB_87DD5B7CC762]
 
Another small step on the long way to control methicillin-resistant Staphylococcus aureus cross-transmission.
Eggimann Philippe, Schrenzel Jacques, 2010. Critical Care Medicine, 38 (1) pp. 311-312. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DAD4086EFDE1]
 
Aspergillosis of the digestive tract
Eggimann Philippe, Bracco David, Pittet Ddier, 2010. pp. 863-888 dans Pasqualotto Alessandro C. (eds.) Aspergillosis : From Diagnosis To Prevention, Springer.
[DOI][serval:BIB_11F8669AFF82]
 
Delay for admission of unstable hospitalized patients to intensive care unit: a need for a medical emergency team?
Pagani J.L., Revelly J.P., Eggimann P., Jolliet P., Schaller M.D., 2010. pp. S303 dans 23rd Annual Meeting of the European Society of Intensive Care Medicine, Intensive Care Medicine. Peer-reviewed.
[WoS][serval:BIB_511B2C138EF4]
 
Early antifungal intervention strategies in ICU patients.
Eggimann Philippe, Ostrosky-Zeichner Luis, 2010. Current Opinion In Critical Care, 16 (5) pp. 465-469.
[DOI][WoS][Pmid][serval:BIB_B0E10E319379]
 
Five-year evolution of drug prescribing in a university adult intensive care unit
Voirol P., Eggimann P., Carron C., Pannatier A., Chiolero R., Wasserfallen J.B., 2010. pp. P473 dans 30th International Symposium on Intensive Care and Emergency Medicine, Critical Care. Peer-reviewed.
[DOI][serval:BIB_0494CF74A196]
 
Impact of chlorhexidine-impregnated sponges on catheter-related infections rate
Eggimann P., Joseph C., Thevenin M.J., Voirol P., Bellini C., Pagani J.L., Revelly J.P., 2010. pp. S128 dans 23rd Annual Meeting of the European Society of Intensive Care Medicine, Intensive Care Medicine. Peer-reviewed.
[WoS][serval:BIB_AB126A200628]
 
Invasive candidiasis in critically ill patients: does progressing knowledge improve clinical management and outcome?
Marchetti Oscar, Eggimann Philippe, Calandra Thierry, 2010. Current Opinion In Critical Care, 16 (5) pp. 442-444.
[DOI][WoS][Pmid][serval:BIB_C52312385096]
 
Monitoring of 1,3-Beta-D-Glucan in High-Risk Surgical ICU Patients for Early Diagnosis of Invasive Candidiasis: a Prospective Study of the Swiss Fungal Infection Network (FUNGINOS)
Tissot F., Lamoth F., Eggiman P., Bille J., Hauser P., Fluckiger U., Siegemund M., Orasch C., Zimmerli S., Calandra T. et al., 2010. dans 50th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
[serval:BIB_E0EA35928242]
 
Pancreatic stone protein (PSP): a biomarker of sepsis
Delodder F., Liaudet L., Que Y.A., Lajaunias F., Graf R., Bain M., Moreillon P., Roger T., Calandra T., Eggimann P., 2010. dans 50th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
[serval:BIB_9D217145E01E]
 
Panobacumab adjunctive immuno-therapy for Pseudomonas aeruginosa hospital-acquired pneumonia versus a cohort group
Lu Q., Dugard A., Eggimann P., Laterre P.F., Mercier E., Wolff M., Chastre J, Giamarellos-Bourboulis E.J., Gafner V.C., Lazar H. et al., 2010. dans 20th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID). Peer-reviewed.
[serval:BIB_A31DFC2BA546]
 
Prophylaxis with systemic antibiotics in patients with severe burns.
Bracco D., Eggimann P., 2010. BMJ, 340 pp. c208.
[DOI][WoS][Pmid][serval:BIB_5E5D36469141]
 
Pseudomonas aeruginosa serotypes in nosocomial pneumonia (NP): prevalence, patients characteristics and clinical outcome.
Lu Q., Dugard A., Eggimann P., Laterre P.F., Mercier E., Wolff M., Chastre J., Tamm W., 2010. dans 50th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
[serval:BIB_2FD1B427CDDA]
 
Reduction of Catheter-Related Infections after Introduction of Chlorhexidine (CHX)-Impregnated Sponges Combined with Transparent Dressings
Joseph C., Thévenin M.J., Voirol P., Bellini B., Revelly J.P., Eggimann P., 2010. dans 50th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Peer-reviewed.
[serval:BIB_0BA733CB19A2]
2009
 
Response to letter to the editor: "Which tobramycin dose is needed in the burn patient?"
Bracco D., Eggimann P., 2009/09. Burns, 35 (6) pp. 904-905.
[serval:BIB_84E19ECBF3C4]
Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients.
Senn L., Eggimann P., Ksontini R., Pascual A., Demartines N., Bille J., Calandra T., Marchetti O., 2009. Intensive Care Medicine, 35 (5) pp. 903-908. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C56A3484A9F2]
 
Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?
Novy J., Carota A., Eggimann P., Pusztaszeri M., Rossetti A.O., Du Pasquier R., 2009. BMJ case reports, 2009 pp. 11 August. Peer-reviewed.
[DOI][Pmid][serval:BIB_BFAD9C19238A]
Impact of bedside open lung biopsies on the management of mechanically ventilated immunocompromised patients with acute respiratory distress syndrome of unknown etiology.
Charbonney E., Robert J., Pache J.C., Chevrolet J.C., Eggimann P., 2009. Journal of Critical Care, 24 (1) pp. 122-128. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8B79D9585BF5]
 
L'hémodialyse intermittente aux soins intensifs = [Intermittent hemodialysis in the intensive care setting]
Kissling S., Schneider A., Eggimann P., Qué Y.A., Burnier M., Vogt B., 2009. Revue Médicale Suisse, 5 (192) pp. 445-450.
[Pmid][serval:BIB_6A4842DD22D3]
On track to limit antifungal overuse!
Eggimann P., Lamoth F., Marchetti O., 2009. Intensive Care Medicine, 35 (4) pp. 582-584. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0D6C7E366DF5]
 
Prevalence and factors of intensive care unit conflicts: the conflicus study.
Azoulay E., Timsit J.F., Sprung C.L., Soares M., Rusinová K., Lafabrie A., Abizanda R., Svantesson M., Rubulotta F., Ricou B. et al., 2009. American Journal of Respiratory and Critical Care Medicine, 180 (9) pp. 853-860. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA1187B450E6]
 
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study.
Stolz D., Smyrnios N., Eggimann P., Pargger H., Thakkar N., Siegemund M., Marsch S., Azzola A., Rakic J., Mueller B. et al., 2009. European Respiratory Journal, 34 (6) pp. 1364-1375. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A0BF96A36EF]
 
The evolution of judgement bias in indirect reciprocity.
Rankin D.J., Eggimann Philippe, 2009. Proceedings. Biological Sciences / The Royal Society, 276 (1660) pp. 1339-1345. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EE79C8B1591C]
Thymoma, immunodeficiency, and herpes simplex virus infections.
Méan M., Schaller M.D., Asner S., Meylan P., Pagani J.L., Tarr P., Eggimann P., 2009. Médecine et Maladies Infectieuses, 39 (5) pp. 344-347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_02437680064E]
2008
Management of catheter-related infection.
Pagani J.L., Eggimann P., 2008/02. Expert Review of Anti-infective Therapy, 6 (1) pp. 31-37.
[URN][DOI][WoS][Pmid][serval:BIB_881422582A3C]
 
Antifungals in the ICU.
Playford E.G., Eggimann P., Calandra T., 2008. Current Opinion in Infectious Diseases, 21 (6) pp. 610-9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4A3D9E46123F]
Gas emission during laparoscopic colorectal surgery using a bipolar vessel sealing device: A pilot study on four patients.
Hübner M., Sigrist M.W., Demartines N., Gianella M., Clavien P.A., Hahnloser D., 2008. Patient Safety in Surgery, 2 (6) p. 22. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0B887A93F7DC]
 
La cohorte sepsis lausannoise: une opportunité de développer la recherche dans le Réseau latin de médecine intensive [Lausanne Cohort of septic patients as an opportunity to develop multidisciplinary research within the Swiss Latin Network of Intensive Care Medicine]
Que Y.A., Eggimann P., Liaudet L., Chioléro R., 2008. Revue Médicale Suisse, 4 (183) pp. 2686-2688, 2690.
[Pmid][serval:BIB_BF39F50FFF0A]
On the way towards eradication of catheter-related infections!
Eggimann P., Zanetti G., 2008. Intensive Care Medicine, 34 (6) pp. 988-990. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8371095E5E7D]
Pharmacokinetic variability of extended interval tobramycin in burn patients.
Bracco D., Landry C., Dubois M.J., Eggimann P., 2008. Burns, 34 (6) pp. 791-796. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A54CC210B396]
2007
 
Infections liées aux cathéters en réanimation: Recommandations pour la pratique clinique. [Management of catheter-related infection: recommendations for clinical practice]
Pagani JL Eggimann P, 2007/12. Revue Médicale Suisse, 3 (137) pp. 2836-9.
[Pmid][serval:BIB_AE17FDC23E14]
Diagnosis of intravascular catheter infection
Eggimann P., 2007/08. Current Opinion in Infectious Diseases, 20 (4) pp. 353-9.
[URN][DOI][WoS][Pmid][serval:BIB_6177AA020949]
Prevention of intravascular catheter infection
Eggimann P., 2007/08. Current Opinion in Infectious Diseases, 20 (4) pp. 360-9.
[URN][DOI][WoS][Pmid][serval:BIB_C14C43BEDBFF]
Single rooms may help to prevent nosocomial bloodstream infection and cross-transmission of methicillin-resistant Staphylococcus aureus in intensive care units
Bracco D., Dubois M. J., Bouali R., Eggimann P., 2007/05. Intensive Care Medicine, 33 (5) pp. 836-40. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CD98BF7544D1]
 
Therapeutic strategies in intensive care units
Eggimann P, 2007. Médecine et Maladies Infectieuses, 37 (Suppl 2) pp. 5-8.
[serval:BIB_FE6538A3A3BB]
2006
 
Fusion de deux services de medecine intensive: quelques observations preliminaires. [Merging of two intensive care units: preliminary observations]
Revelly J. P., Eggimann P., Oddo M., Eckert P., Liaudet L., Berger M. M., Schaller M. D., Wasserfallen J. B., Chiolero R., 2006/12. Revue Médicale Suisse, 2 (91) pp. 2871-4.
[Pmid][serval:BIB_A9D37667DA14]
Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature
Eggimann P., Chevrolet J. C., Starobinski M., Majno P., Totsch M., Chapuis B., Pittet D., 2006/12. Infection, 34 (6) pp. 333-8.
[URN][DOI][WoS][Pmid][serval:BIB_F57177B88721]
 
Is there really a survival benefit of SDD in burns?
Eggimann P., Chiolero R. L., Raffoul W., Voirol P., Berger M. M., 2006/08. Annals of Surgery, 244 (2) pp. 325-6; author reply 326-7.
[DOI][WoS][Pmid][serval:BIB_A9FDDB525551]
Treatment options of invasive fungal infections in adults.
Flückiger U., Marchetti O., Bille J., Eggimann P., Zimmerli S., Imhof A., Garbino J., Ruef C., Pittet D., Täuber M. et al., 2006/07/22. Swiss medical weekly, 136 (29-30) pp. 447-463. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_B671A5617F0E]
 
Should antibiotic combinations be used to treat ventilator-associated pneumonia?
Eggimann P., Revelly J.P., 2006/02. Seminars in Respiratory and Critical Care Medicine, 27 (1) pp. 68-81. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_12046C49DCC7]
 
A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia
Kollef M., Pittet D., Sanchez Garcia M., Chastre J., Fagon J. Y., Bonten M., Hyzy R., Fleming T. R., Fuchs H., Bellm L. et al., 2006/01. American Journal of Respiratory and Critical Care Medicine, 173 (1) pp. 91-7.
[DOI][WoS][Pmid][serval:BIB_6226658075C7]
 
Epidemiology and impact of catheter-related infections
Eggimann P., Pittet D., 2006. pp. 1-24 dans Seifert H., Jansen B., Farr B.M. (eds.) Catheter-Related Infections chap. 1, Marcel Dekker.
[serval:BIB_1E91DE5457AC]
 
Non antibiotic prophylaxis of infections in the ICU
Pittet D., Uçkay I., Sax H., Eggimann P., 2006. pp. 71-86 dans Albert R., Slutsky A., Ranieri V.M., Takala J., Torres A. (eds.) Clinical Critical Care Medicine chap. 8, Mosby.
[serval:BIB_300D9DD66635]
 
Postoperative fungal infections.
Eggimann P., Pittet D., 2006. Surgical Infections, 7 Suppl 2 (Suppl 2) pp. S53-S56.
[DOI][Pmid][serval:BIB_34E73D93058A]
Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics
Eggimann P., Jamdar S., Siriwardena A. K., 2006. Critical Care, 10 (5) p. 229.
[URN][DOI][WoS][Pmid][serval:BIB_A0DA346CF68F]
Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials
Berger M. M., Eggimann P., Heyland D. K., Chiolero R. L., Revelly J. P., Day A., Raffoul W., Shenkin A., 2006. Critical Care, 10 (6) pp. R153.
[URN][DOI][WoS][Pmid][serval:BIB_AB6D58C35858]
2005
Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed?
Eggimann P., Wolff M., Garbino J., 2005/11. Intensive Care Medicine, 31 (11) pp. 1466-1468.
[URN][DOI][WoS][Pmid][serval:BIB_8C84C8296B95]
 
Long-term reduction of vascular access-associated bloodstream infection
Eggimann P., Hugonnet S., Sax H., Harbarth S., Chevrolet J. C., Pittet D., 2005/05. Annals of Internal Medicine, 142 (10) pp. 875-6.
[WoS][Pmid][serval:BIB_4CAD5ECDE2F9]
 
Acute bacteremias
Eggimann P., Pittet D., 2005. pp. 456-467 dans Fink M.P., Abraham E., Kochanek P., Vincent J.L. (eds.) Textbook of Critical Care chap. 155, Saunders.
[serval:BIB_6AA90E091BCD]
 
Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists.
Eggimann P., Calandra T., Fluckiger U., Bille J., Garbino J., Glauser M.P., Marchetti O., Ruef C., Täuber M., Pittet D., 2005. Intensive care medicine, 31 (11) pp. 1514-21. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A18308CBA34A]
 
Réactualisation de la douzième conférence de consensus de la Société de réanimation de langue française (SRLF) : infections liées aux cathéters veineux centraux en réanimation [Updating of the 12th consensus conference of the Société de Réanimation de langue française (SRLF) : catheter related infections in Intensive Care unit]
Timsit J.F., 2005. Annales Françaises d'Anesthésie et Réanimation, 24 (3) pp. 315-22. Peer-reviewed.
[DOI][Pmid][serval:BIB_E1BAC3D41925]
 
Stratégies destinées a optimiser l'utilisation des antibiotiques en réanimation [Strategies targeted at optimising antimicrobial therapy in critically ill patients]
Eggimann P., Oddo M., Voirol P., Zanetti G., Chioléro R., 2005. Revue médicale suisse, 1 (45) pp. 2928-32.
[Pmid][serval:BIB_EEA63AF97692]
2004
 
Impact of ventilator-associated pneumonia on resource utilization and patient outcome
Hugonnet S., Eggimann P., Borst F., Maricot P., Chevrolet J. C., Pittet D., 2004/12. Infection Control and Hospital Epidemiology, 25 (12) pp. 1090-6.
[DOI][WoS][Pmid][serval:BIB_674FE97D775A]
 
Catheter-related infections
Eggimann P., Sax H., Pittet D., 2004/09. Microbes and Infection, 6 (11) pp. 1033-42.
[DOI][WoS][Pmid][serval:BIB_AE7948C15E92]
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000
Marchetti O., Bille J., Fluckiger U., Eggimann P., Ruef C., Garbino J., Calandra T., Glauser M. P., Tauber M. G., Pittet D., 2004/02. Clinical Infectious Diseases, 38 (3) pp. 311-20.
[URN][DOI][WoS][Pmid][serval:BIB_182048CCAD71]
 
Education as primary tool for prevention
Eggimann P., Pittet D., 2004. pp. 127-138 dans O'Grady N.P., Pittet D. (eds.) Catheter-related infections in the critically ill chap. 9, Kulwer Academic Publishers.
[serval:BIB_AEB802D7C6E3]
Nosocomial bloodstream infection and clinical sepsis
Hugonnet S, Sax H, Eggimann P., Touveneau S., Chevrolet J.C., Pittet D., 2004. Emerging Infectious Diseases, 10 (1) pp. 76-81. Peer-reviewed.
[URN][WoS][Pmid][serval:BIB_AA79944481F7]
 
Optimalisation de l'utilisation des antibiotiques en réanimation
Pittet D., Eggimann P., Harbarth S., Sax H., 2004. Swiss-Noso, 11 (2) pp. 9-15.
[serval:BIB_D62A5D1CC5CD]
 
Stratégies visant à optimiser l'utilisation des agents antimicrobiens en réanimation
Eggimann P., Pittet D., 2004., MAPAR pp. 237-247 dans MAPAR (eds.) Communications scientifiques MAPAR 2004, 22e Journées internationales de mises au point en anesthésie-réanimation, MAPAR.
[serval:BIB_9D700CB3C4E5]
2003
 
Management of Candida species infections in critically ill patients
Eggimann P., Garbino J., Pittet D., 2003/12. Lancet Infectious Diseases, 3 (12) pp. 772-85.
[DOI][WoS][Pmid][serval:BIB_FE4B8BF88A77]
 
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann P., Garbino J., Pittet D., 2003/11. Lancet Infectious Diseases, 3 (11) pp. 685-702.
[DOI][WoS][Pmid][serval:BIB_572D9927D091]
 
Ventilator-associated pneumonia: caveats for benchmarking
Eggimann P., Hugonnet S., Sax H., Touveneau S., Chevrolet J. C., Pittet D., 2003/11. Intensive Care Medicine, 29 (11) pp. 2086-9.
[DOI][WoS][Pmid][serval:BIB_B5A6756C9841]
 
Acute respiratory distress syndrome after bacteremic sepsis does not increase mortality
Eggimann P., Harbarth S., Ricou B., Hugonnet S., Ferriere K., Suter P., Pittet D., 2003/05. American Journal of Respiratory and Critical Care Medicine, 167 (9) pp. 1210-4.
[DOI][WoS][Pmid][serval:BIB_0FFA09118BC9]
 
Hygiène des mains et utilisation des solutions hydro-alcooliques en réanimation. Communications scientifiques MAPAR 2003
Eggimann P., Pittet D., 2003., MAPAR pp. 365-377 dans MAPAR (eds.) Communications scientifiques MAPAR 2003, 21e Journées internationales de mises au point en anesthésie-réanimation, MAPAR.
[serval:BIB_7E4CA2ECBC89]
 
Infections nosocomiales : interventions et qualité des soins [Maladies infectieuses = Nosocomial infections : quality improvement interventions]
Eggimann P., Pittet D., 2003. Médecine et Hygiène, 61 (2431) pp. 708-713.
[serval:BIB_284F5E517D41]
 
Micro-ordinateurs de poche : du gadget à l'irremplaçable [Handheld computers: the gadget that became an invaluable tool]
Tschopp M., Eggimann P., 2003. Médecine et Hygiène, 61 (2435) pp. 913-916.
[serval:BIB_EA37D6800665]
 
Physiopathologie et prévention des infections liées aux accès vasculaires [Pathophysiology and prevention of intravascular catheter-related infection]
Eggimann P., Pittet D., 2003. Medecine et Maladies Infectieuses, 33 (11) pp. 554-563. Peer-reviewed.
[DOI][WoS][serval:BIB_9E64D98C54BC]
2002
 
Intensive care unit-acquired infections: is postdischarge surveillance useful?
Hugonnet S., Eggimann P., Sax H., Touveneau S., Chevrolet J.C., Pittet D., 2002/12. Critical care medicine, 30 (12) pp. 2636-2638. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2B995B913EF]
 
Overview of catheter-related infections with special emphasis on prevention based on educational programs.
Eggimann P., Pittet D., 2002/05. Clinical Microbiology and Infection, 8 (5) pp. 295-309. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB349D10B87D]
 
Candida : quand traiter, comment et pourquoi ? [Candida: when to treat, how and why?]
Eggimann P., Garbino J., Pittet D., 2002. Médecine et Hygiène, 60 (2405) pp. 1660-1666.
[serval:BIB_DBB1B5BE62FC]
 
Candidoses en réanimation [Candidiasis and intensive care patients]
Eggimann P., Pittet D., 2002. Réanimation, 11 (3) pp. 209-221.
[DOI][serval:BIB_6478A8644300]
 
Infections fongiques sévères en réanimation
Eggimann P., Calandra T., 2002. pp. 519-555 dans Charbonneau P, Praz G, Glauser MP (eds.) Pathologies infectieuses en réanimation chap. 21, Elsevier.
[serval:BIB_869B5F6599E5]
 
Infections liées aux accès vasculaires : épidémiologie, pathogénie, traitement et nouvelles méthodes de prévention [Catheter-related infections : epidemiology, pathogenesis, treatment and prevention]
Eggimann P., Pittet D., 2002. Nutrition Clinique et Métabolisme, 16 (1) pp. 62-65. Peer-reviewed.
[DOI][serval:BIB_1C4DC4E400FB]
 
L'endocardite infectieuse (2e partie)
Cavassini M., Eggimann P., Moreillon P., Francioli P., 2002. Swiss Medical Forum = Forum Médical Suisse 34 pp. 781-788.
[serval:BIB_4DFB4C11081A]
 
L'endocardite infectieuse [1ère partie]
Cavassini M., Eggiman P., Francioli P., 2002. Swiss Medical Forum = Forum Médical Suisse, 2 (32-33) pp. 759-764.
[serval:BIB_5135E2BEA560]
 
Programme hospitaliers de prévention des infections nosocomiales appliqués aux infections liées aux accès vasculaires
Eggimann P., Pittet D., 2002. Actualités en Réanimation et Urgences pp. 155-166.
[serval:BIB_0A7C46FDF949]
 
Prophylaxie des candidoses en réanimation
Eggimann P., Pittet D., 2002. pp. 79-94 dans Weinbreck P., Grillot R., Herbrecht R., Lortholary O., Montravers P., Wolf M. (eds.) Infections fongiques : résistances et nouvelels modalités thérapeutiques chap. 4, Optimed.
[serval:BIB_F51A2B5FF35B]
 
Quand rajouter un traitement antifongique chez un malade septique?
Eggimann P., Pittet D., 2002., MAPAR pp. 451-460 dans MAPAR (eds.) Communications scientifiques MAPAR 2002, 20e Journées internationales de mises au point en anesthésie-réanimation, MAPAR.
[serval:BIB_51441246714D]
 
Why, when and how to isolate the septic patient?
Rubinovitch B., Eggimann P., Pittet D., 2002. pp. 581-608 dans Vincent J.L., Carlet J., Opal S.M. (eds.) The sepsis text chap. 33, Kluwer academic publishers.
[serval:BIB_D0234CDB9C36]
2001
 
Infection control in the ICU
Eggimann P., Pittet D., 2001/12. Chest, 120 (6) pp. 2059-93.
[DOI][WoS][Pmid][serval:BIB_EE1AB4E20405]
 
Prevention of ventilator-associated pneumonia by oral decontamination: just another SDD study?
Pittet D., Eggimann P., Rubinovitch B., 2001/08. American Journal of Respiratory and Critical Care Medicine, 164 (3) pp. 338-9.
[WoS][Pmid][serval:BIB_3F8146950296]
 
Candidoses du sujet non neutropénique: de la colonisation à l'infection [Candidiasis among non-neutropenic patients: from colonization to infection]
Eggimann P., Pittet D., 2001/04. Annales Françaises d'Anesthésie et de Réanimation, 20 (4) pp. 382-388. Peer-reviewed.
[WoS][Pmid][serval:BIB_74D24CE169D1]
 
Myocardite : l'attitude reste pragmatique! [Myocarditis: practical approach]
Katz E., Eggimann P., 2001. Médecine et Hygiène, 59 (2346) pp. 1069-1074.
[serval:BIB_A8E6DCBA5C6B]
 
New strategies to prevent catheter-related infections in intensive care units
Eggiman P., Pittet D., 2001. pp. 135-150 dans Vincent J.L. (eds.) Yearbook of Intensive Care and Emergency Medicine 2001, Springer.
[serval:BIB_116426D50870]
 
Nonantibibiotic measures for the prevention of Gram-positive infections.
Eggimann P., Pittet D., 2001. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 7 Suppl 4 (Suppl. 4) pp. 91-99. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F300F4BD6A6]
 
Prévention des candidoses systémiques
Eggimann P., Pittet D., 2001. pp. 69-84 dans Weinbreck P., Grillot R., Herbrecht R., Lortholary O., Montravers P., Wolf M. (eds.) Candidoses systémiques chap. 4, Optimed.
[serval:BIB_AE5DB67532C5]
 
Ventilator-associated pneumonia
Eggimann P., Pittet D., 2001. pp. 20-35 dans Wilcox Mark H. (eds.) Infection Highlights, Health Press.
[serval:BIB_83A21BF187E2]
2000
 
Candidoses invasives en reanimation. [Invasive candidiasis in critically ill patients]
Eggimann P., Pittet D., 2000/10. Schweizerische Medizinische Wochenschrift, 130 (42) pp. 1525-37.
[WoS][Pmid][serval:BIB_C0C1228408B7]
 
Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care
Eggimann P., Harbarth S., Constantin M. N., Touveneau S., Chevrolet J. C., Pittet D., 2000/05. Lancet, 355 (9218) pp. 1864-8.
[DOI][WoS][Pmid][serval:BIB_5A3F3ABA5387]
Catheter-related infections in intensive care units : an overview with special emphasis on prevention
Eggimann P, Pittet D., 2000. Advances in Sepsis, 1 (1) pp. 2-15.
[URN][serval:BIB_17C7577D31C7]
 
Pacemaker infections
Eggimann P., Waldvogel F., 2000. pp. 247-64 dans Waldvogel F., Bisno A. (eds.) Infections associated with indwelling medical devices chap. 12, American Society of Microbiology Press.
[serval:BIB_3917C2F6ABC7]
1999
 
Approche diagnostique et prise en charge des hémoptysies massives [Management of massive hemoptysis : a multidisciplinary approach]
Eggimann P., Bracco D., 1999. Médecine et Hygiène, 57 (2276) pp. 2136-2143.
[serval:BIB_211AB01FE7F3]
 
Catheter-related infections in intensive care units : owerview and update
Eggimann P., Pittet D., 1999. pp. 95-100 dans Vincent J.L. (eds.) Yearbook of Intensive Care and Emergency Medicine 1999 chap. 12, Springer.
[serval:BIB_C6DA56AAAF68]
 
Central line sepsis in intensive care units : overview and update
Eggimann P., Pittet D., 1999. Current Anaesthesia and Critical Care, 10 (1) pp. 14-20.
[DOI][serval:BIB_CC5F0F4149D3]
 
Fever in neutropenic cancer patients : a structured approach
Eggimann P., 1999. Intensivmedizin und Notfallmedizin, 36 (6) pp. 514-525. Peer-reviewed.
[DOI][serval:BIB_81C429C66F32]
 
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.
Eggimann P., Francioli P., Bille J., Schneider R., Wu M.M., Chapuis G., Chiolero R., Pannatier A., Schilling J., Geroulanos S. et al., 1999. Critical care medicine, 27 (6) pp. 1066-72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_72782E55BABA]
 
High-dose intravenous immunoglobulin treatment and cerebral vasospasm : a possible mechanism of ischemic encephalopathy?
Sztajzel R., Le Floch-Rohr J., Eggimann P., 1999. European Neurology, 41 (3) pp. 153-158. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5A8758DBE8CD]
 
Sepsis liées aux accès vasculaires : mise au point, développements récents et prévention [Catheter-related infections : owerview and lipdate]
Eggimann P., Pittet D., 1999. Médecine et Hygienne, 57 (2255) pp. 1016-1020.
[serval:BIB_AED25BB22C2C]
1998
 
150 ans d'hygiène hospitalière : quelques sujets brûlants : compte rendu de congrès
Eggimann P., 1998. pp. 545-548 dans Assemblée annuelle de la Société suisse d'hygiène hospitalière, Médecine et Hygiène.
[serval:BIB_8451871EBB9D]
 
Anticorps anti-TNF dans le traitement du choc septique : la fin du rêve ?
Eggimann P., 1998. Schweizerische Medizinische Wochenschrift = Journal Suisse de Médecine, 128 (33) p. 1231. Peer-reviewed.
[serval:BIB_D5F6EDEA58BF]
 
Management of fever in cancer patients with acquired neutropenia
Eggimann P., 1998. pp. 339-50 dans Vincent J.L. (eds.) Yearbook of Intensive Care and Emergency Medicine 1998 chap. 30, Springer.
[serval:BIB_6679A7582EA8]
 
Place de la vaccination anti-pneumococcique
Eggimann P., Rothmeier C., 1998. Pyrexie, 2 pp. 147-151.
[serval:BIB_8978BBE2B2C8]
1997
 
A qui administrer le vaccin anti-pneumococcique? [We should received and pneumococcal immunization?]
Eggimann P., Rothmeier C., 1997/06. Medecine et Hygiene, 55 (2163) pp. 992-995.
[serval:BIB_8AEC7ED4E514]
1996
 
Quadriparesia following permissive hypercapnia and inhalational anesthesia in a patient with severe status asthmaticus.
Zender H.O., Eggimann P., Bulpa P., Chevrolet J.C., Jolliet P., 1996. Intensive Care Medicine, 22 (9) p. 1001.
[DOI][WoS][Pmid][serval:BIB_94192279384F]
1995
 
Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs
Eggimann P., Chiolero R., Chassot P. G., Lienard D., Gerain J., Lejeune F., 1995/04. Chest, 107 (4) pp. 1074-82.
[DOI][WoS][Pmid][serval:BIB_220D890D5ED1]
 
Bacteremia Due to Oral Viridans Streptococci in Neutropenic Patients with Cancer: Cytostatics Are a More Important Risk Factor than Antibacterial Prophylaxis - Reply
Bochud P.Y., Eggimann P., Calandra T., Vanmelle G., Saghafi L., Francioli P., 1995. Clinical Infectious Diseases, 20 (2) p. 470.
[WoS][serval:BIB_F47CF8121254]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University